Takeda Slated to Launch Japan PI/II for Moderna Shot in January

Takeda Pharmaceutical will kick off a Japan PI/II study for Moderna’s mRNA-based COVID-19 vaccine as early as next month, according to a person familiar with the matter. The placebo-controlled trial is designed to gauge its safety and immunogenicity in 200...read more